Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
Phase 2
Completed
- Conditions
- Bipolar Disorder With Manic or Mixed Episodes
- First Posted Date
- 2006-09-12
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT00374920
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Memory Pharmaceuticals
- Target Recruit Count
- 183
- Registration Number
- NCT00257673
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath